NASDAQ:ANCN
Delisted
Anchiano Therapeutics Ltd Stock News
$4.47
+0 (+0%)
At Close: Aug 17, 2022
Anchiano Therapeutics to Present at the Baird 2019 Global Healthcare Conference
12:00pm, Tuesday, 03'rd Sep 2019
CAMBRIDGE, Mass., Sept. 03, 2019 -- Anchiano Therapeutics Ltd. (Nasdaq: ANCN) (“Anchiano”), a pivotal-stage biopharmaceutical company focused on the discovery and development.
Anchiano Therapeutics Reports Second Quarter 2019 Financial Results
09:15pm, Monday, 05'th Aug 2019
CAMBRIDGE, Mass., Aug. 05, 2019 -- Anchiano Therapeutics Ltd. (Nasdaq: ANCN) (“Anchiano”), a pivotal-stage biopharmaceutical company focused on the discovery and development of.
Anchiano Therapeutics Delists Ordinary Shares from the Tel Aviv Stock Exchange
12:30pm, Tuesday, 18'th Jun 2019
CAMBRIDGE, Mass., June 18, 2019 -- Anchiano Therapeutics Ltd. (Nasdaq: ANCN) (“Anchiano”), a pivotal-stage biopharmaceutical company focused on the discovery and development of.
